About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in California | 676 Studies

Clinical Trials Pancreatic CancerCalifornia

Pancreatic Cancer Clinical Trials in California

Find 676 clinical trials for pancreatic cancer near California. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 481-500 of 676 trials

CompletedMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)The primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict response of patients…NCT05461430·Oakland, California CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably.NCT06084481·Duarte, California and 53 others

CompletedIntegrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy VolunteersThis pilot clinical trial studies the use of integrin alpha-v-beta \[18F\]-R01-MG-F2 Positron Emission Tomography/Computed Tomography (PET/CT) and Positron Emission…NCT02683824·Palo Alto, California

CompletedImproving Informed Consent for Palliative ChemotherapyPatients are routinely asked to sign an "informed consent" document prior to starting chemotherapy, indicating they understand the risks and benefits of treatment.NCT02282722·San Francisco, California and 7 others

RecruitingKO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsThis first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess KO-2806, a farnesyltransferase inhibitor (FTI), as a monotherapy and in combination, in…NCT06026410·Phoenix, Arizona and 37 others

CompletedGemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00004861·Los Angeles, California and 15 others

CompletedCapecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine TumorsThe purpose of this research is to evaluate the effectiveness and safety of a combination of capecitabine, temozolomide and bevacizumab in the treatment of advanced pancreatic…NCT01525082·Stanford, California

Active not recruitingA Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)The study aims to determine maximum tolerated dose (MTD) or recommended combination dose of the MTA-cooperative PRMT5 inhibitor Anvumetostat administered in combination with other…NCT06360354·Bakersfield, California and 76 others

RecruitingTo Evaluate the Preliminary Efficacy of Our Digitally Enhanced CHW-led Intervention in Newly Diagnosed PDACThe goal of this clinical trial is to learn if a community health worker led intervention that helps facilitate palliative care works to treat newly-diagnostic pancreatic cancer.NCT07591571·Loma Linda, California

TerminatedStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsThis study evaluates ADCT-301 in patients with Selected Advanced Solid Tumors.NCT03621982·Palo Alto, California and 8 others

TerminatedMonoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Monoclonal antibodies, such as RAV12, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread.NCT00625586·South San Francisco, California and 1 other

RecruitingA Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) MutationThe main purpose of the trial is to assess whether the trial drug, KST-6051, is safe and tolerable when administered orally to adults with advanced or metastatic solid tumors with…NCT07458347·Los Angeles, California and 8 others

RecruitingIncreasing Germline Genetic Testing for Patients With CancerGermline testing for hereditary cancer syndromes is underutilized across most health care settings.NCT07307664·Los Angeles, California and 9 others

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

UnknownSecond-line Study of PEGPH20 and Pembro for HA High Metastatic PDACThis study is the study of the combination of PEGPH20 and Pembrolizumab (MK-3475) for patients with previously treated Hyaluronan High (HA-high) metastatic pancreatic ductal…NCT03634332·Gilbert, Arizona and 4 others

CompletedA Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid TumorsThis is a Phase 1 dose escalation to assess the safety, tolerability and maximum tolerated dose of subcutaneous administered SDX-7320 in patients with advanced refractory or…NCT02743637·Scottsdale, Arizona and 2 others

Active not recruitingA Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR MutationsA Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and recommended Phase II dose of…NCT05163028·Duarte, California and 11 others

Active not recruitingTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerThis phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer…NCT04340141·Birmingham, Alabama and 452 others

CompletedStudy of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal CancersThis study is for people with advanced cancer of the digestive tract and cancer that cannot be completely removed by surgery.NCT00183846·Los Angeles, California

PreviousPage 25 of 34Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia